miRNA as a liquid biomarker to detect malignancy in small testicular masses
J. Chavarriaga, Ruth Hamilton(Royal Hospital for Children), George M. Yousef(University Health Network), Cármen Jerónimo(Universidade do Porto), Helga Wagner, Keith Jarvi(University of Toronto), Nuno Tiago Tavares(Instituto Português de Oncologia Francisco Gentil), Lynn Anson‐Cartwright(University Health Network), Katherine Lajkosz(University Health Network), Adam Bobrowski, Ricardo Leão(Hospital Braga), Lucia Nappi(University of British Columbia), João Lobo(Universidade do Porto), Carley Langleben(Princess Margaret Cancer Centre), Qiang Ding, Susan Prendeville(University of Toronto), Martin O’Malley(Princess Margaret Cancer Centre), Sajjad Janfaza
Cited by 0
Related Papers
Integrative epigenetic taxonomy of primary prostate cancer
|Nature Communications|2018|167
miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215
|British Journal of Cancer|2011|163
Human Germ Cell Tumors are Developmental Cancers: Impact of Epigenetics on Pathobiology and Clinic
|International Journal of Molecular Sciences|2019|141
Data Sharing Under the General Data Protection Regulation
|Hypertension|2021|136
Application of miRNAs in the diagnosis and monitoring of testicular germ cell tumours
|Nature Reviews Urology|2020|112